Comparison of two flow cytometric methods for detection of aneuploidy in multiple myeloma:: Implications for investigation of residual disease

被引：0
|
作者：
Oelschlaegel, U [1 ]
Nowak, R [1 ]
Heider, T [1 ]
Naumann, R [1 ]
Bornhäuser, M [1 ]
Ehninger, G [1 ]
机构：
[1] Univ Hosp, Med Clin 1, Dresden, Germany
来源：
EXPERIMENTAL HEMATOLOGY | 2003年 / 31卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
184
引用
收藏
页码：121 / 122
页数：2
相关论文
共 50 条
  • [21] Molecular detection of minimal residual disease in multiple myeloma
    Bai, Yinlei
    Orfao, Alberto
    Sang Chim, Chor
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (01) : 11 - 26
  • [22] Flow Cytometric Reticulocyte Counting: A Comparison Between Two Methods
    Maconi, M.
    Danise, P.
    Cavalca, L.
    Formisano, D.
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2010, 24 (04) : 252 - 255
  • [23] Flow cytometric detection of minimal residual disease in acute lymphoblastic leukemia
    Dworzak, MN
    Panzer-Grümayer, ER
    LEUKEMIA & LYMPHOMA, 2003, 44 (09) : 1445 - 1455
  • [24] Minimal residual disease in multiple myeloma: Benefits of flow cytometry
    Galtseva, I. V.
    Davydova, Y. O.
    Kapranov, N. M.
    Julhakyan, H. L.
    Mendeleeva, L. P.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (01) : 12 - 20
  • [25] Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
    Flores-Montero, J.
    Sanoja-Flores, L.
    Paiva, B.
    Puig, N.
    Garcia-Sanchez, O.
    Boettcher, S.
    van der Velden, V. H. J.
    Perez-Moran, J-J
    Vidriales, M-B
    Garcia-Sanz, R.
    Jimenez, C.
    Gonzalez, M.
    Martinez-Lopez, J.
    Corral-Mateos, A.
    Grigore, G-E
    Fluxa, R.
    Pontes, R.
    Caetano, J.
    Sedek, L.
    del Canizo, M-C
    Blade, J.
    Lahuerta, J-J
    Aguilar, C.
    Barez, A.
    Garcia-Mateo, A.
    Labrador, J.
    Leoz, P.
    Aguilera-Sanz, C.
    San-Miguel, J.
    Mateos, M-V
    Durie, B.
    van Dongen, J. J. M.
    Orfao, A.
    LEUKEMIA, 2017, 31 (10) : 2094 - 2103
  • [26] Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
    J Flores-Montero
    L Sanoja-Flores
    B Paiva
    N Puig
    O García-Sánchez
    S Böttcher
    V H J van der Velden
    J-J Pérez-Morán
    M-B Vidriales
    R García-Sanz
    C Jimenez
    M González
    J Martínez-López
    A Corral-Mateos
    G-E Grigore
    R Fluxá
    R Pontes
    J Caetano
    L Sedek
    M-C del Cañizo
    J Bladé
    J-J Lahuerta
    C Aguilar
    A Bárez
    A García-Mateo
    J Labrador
    P Leoz
    C Aguilera-Sanz
    J San-Miguel
    M-V Mateos
    B Durie
    J J M van Dongen
    A Orfao
    Leukemia, 2017, 31 : 2094 - 2103
  • [27] MINIMAL RESIDUAL DISEASE DETECTION BY NEXT GENERATION FLOW-MRD IN MULTIPLE MYELOMA PATIENTS
    Sirianni, S.
    Gozzetti, A.
    Candi, V.
    Bocchia, M.
    Raspadori, D.
    HAEMATOLOGICA, 2016, 101 : S87 - S87
  • [28] Detection of residual malignant cells in leukapheresis products of patients with hematopoietic diseases with two flow cytometric methods.
    Oelschlagel, U
    Nowak, R
    Bornhauser, M
    Zengler, H
    Hofmann, R
    Schafer, J
    Ehninger, G
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 618 - 618
  • [29] Detection of minimal residual disease in multiple myeloma and acute leukaemia
    Bakkus, MHC
    JugeMorineau, N
    tenBosch, JEV
    MEDICAL ONCOLOGY, 1996, 13 (02) : 121 - 131
  • [30] Progress in the application of minimal residual disease detection in multiple myeloma
    Xiaojia Zuo
    Dingsheng Liu
    Journal of Hematopathology, 2021, 14 : 97 - 107
12345